A critical role of ceramide accumulation in insulin-target tissues during obesity development and its link to the manifestation of insulin resistance in vivo has been mainly determined by the rate of insulin-stimulated AKT phosphorylation in key metabolic tissues of rodent models after ceramide-lowering interventions. The gene discussed is INS; the disease is Insulin resistance.